In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia
- PMID: 21397441
- DOI: 10.1016/j.jvs.2010.12.055
In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia
Abstract
Objectives: Catheter-based revascularization has emerged as an alternative to surgical bypass for the tibioperoneal vessels. The purpose of this analysis was to describe the outcomes of tibial angioplasty interventions for critical limb ischemia (CLI) in the hospitalized Medicare population, to examine in-hospital complications, to define the 30-day readmission and mortality rates, and to assess secondary procedures performed in this population.
Methods: In-patients with CLI undergoing tibioperoneal angioplasty were identified using The Centers for Medicare & Medicaid Services in-patient claims for 2005 to 2007. In-hospital complications, mortality, 30-day secondary procedures, and 30-day rehospitalization after discharge were described.
Results: A total of 13,258 in-patients underwent tibioperoneal angioplasty (54.2% men; 75.7% white, 17.1% African American; 42.8% gangrene, 46.7% rest pain, 10.5% claudication) and 29.3% had a stent, 47.3% had femoral-popliteal angioplasty, and 20.1% had atherectomy during their initial procedure. Initial hospital complications included renal complications (8.1%), respiratory complications and pneumonia (5.1%), and cardiac complications with acute myocardial infarction (3.2%). Mortality in-hospital was 2.8% and at 30 days was 6.7%. Thirty-day rehospitalization rate was 29.6%. Thirty-day reinterventions included repeat angiogram (8.5%), repeat tibioperoneal angioplasty (3.2%), open bypass (2.1%), and lower extremity amputations (23.8%). Gangrene was the most frequent diagnosis at rehospitalization (13.5%). Patients with gangrene as an indication for tibioperoneal angioplasty were 1.8 times (95% confidence interval [CI], 1.56-2.10) as likely as patients with rest pain to be rehospitalized during 30 days after discharge. Among comorbidities, predictors of 30-day rehospitalization included chronic renal failure (odds ratio [OR], 1.4; 95% CI, 1.27-1.52), chronic pulmonary disease (OR, 1.1; 95% CI, 1.01-1.25), and congestive heart failure (CHF; OR, 1.1; 95% CI, 1.01-1.22). About one-quarter of patients (23.8%) within 30 days after their initial procedure underwent amputation at any level of the lower limb.
Conclusion: Tibioperoneal angioplasty is associated with frequent in-hospital complications, an overall 30-day amputation rate of 23.8% for all procedures and indications, and a 30-day rehospitalization rate of almost 30%. Further detailed analysis of tibioperoneal intervention is essential to define best treatment strategies and to minimize complications and readmission rates.
Copyright © 2011 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.
Similar articles
-
Six-Month Freedom From Amputation Rates and Quality of Life Following Tibial and Pedal Endovascular Revascularization for Critical Limb Ischemia.Vasc Endovascular Surg. 2019 Apr;53(3):212-215. doi: 10.1177/1538574418823378. Epub 2019 Jan 8. Vasc Endovascular Surg. 2019. PMID: 30618346
-
Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia.Ann Vasc Surg. 2018 Oct;52:96-107. doi: 10.1016/j.avsg.2018.03.011. Epub 2018 May 17. Ann Vasc Surg. 2018. PMID: 29777842
-
Increased preoperative pulse pressure predicts procedural complications and mortality in patients who undergo tibial interventions for critical limb ischemia.J Vasc Surg. 2016 Mar;63(3):673-677. doi: 10.1016/j.jvs.2015.09.033. Epub 2015 Nov 11. J Vasc Surg. 2016. PMID: 26577658 Free PMC article.
-
Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease.J Vasc Surg. 2014 Feb;59(2):409-418.e3. doi: 10.1016/j.jvs.2013.07.114. Epub 2013 Sep 29. J Vasc Surg. 2014. PMID: 24080134 Free PMC article.
-
Longitudinal outcomes after tibioperoneal angioplasty alone compared to tibial stenting and atherectomy for critical limb ischemia.Vasc Endovascular Surg. 2013 Oct;47(7):507-12. doi: 10.1177/1538574413495467. Epub 2013 Jul 12. Vasc Endovascular Surg. 2013. PMID: 23853224
Cited by
-
Sex-Related Differences in the Outcomes of Endovascular Interventions for Chronic Limb-Threatening Ischemia: Results from the LIBERTY 360 Study.Vasc Health Risk Manag. 2020 Jul 8;16:271-284. doi: 10.2147/VHRM.S246528. eCollection 2020. Vasc Health Risk Manag. 2020. PMID: 32753875 Free PMC article.
-
Two-year clinical outcomes following lower limb endovascular revascularisation for chronic limb-threatening ischaemia at a tertiary Asian vascular centre in Singapore.Singapore Med J. 2022 Feb;63(2):79-85. doi: 10.11622/smedj.2020104. Epub 2020 Jul 16. Singapore Med J. 2022. PMID: 32668837 Free PMC article.
-
Complex relationship between low albumin level and poor outcome after lower extremity procedures for peripheral artery disease.J Vasc Surg. 2021 Jan;73(1):200-209. doi: 10.1016/j.jvs.2020.04.524. Epub 2020 May 26. J Vasc Surg. 2021. PMID: 32470524 Free PMC article.
-
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006. Epub 2019 Jun 8. Eur J Vasc Endovasc Surg. 2019. PMID: 31182334 Free PMC article.
-
Global vascular guidelines on the management of chronic limb-threatening ischemia.J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28. J Vasc Surg. 2019. PMID: 31159978 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous